Q1 2025 saw lower sales and negative earnings, but operational improvements and early Q2 order recovery signal a gradual turnaround. Management remains cautious due to market uncertainty and potential US tariff impacts.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.